The global blood culture tests market is forecast to grow at a CAGR of 7.25% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: Demand for rapid diagnostic tests will be a key trend for market growth. Rapid identification of microorganisms in clinical laboratories is of great value for the selection of optimal patient management strategies for inhibiting bacteria, viruses, fungi, mycobacteria, and parasites.
There is a critical need for new technologies in the area of clinical microbiology, particularly for detecting BSIs that are responsible for the highest number of deaths worldwide. Rapid diagnostics tests offer rapid identification of pathogens, are cost-effective to a certain extent, and help in the effective targeting of antimicrobial therapy in hospitals.
According to the report, use of automated blood culture systems will be a key driver for market growth. Blood culture tests that involve most of the microbiological studies are the second-most common procedure performed in medical settings to detect BSIs.
Advanced automated systems such as BS's BacT/ALERT system, AccuMed International's ESP Culture system II, and Cepheid's GeneXpert system used for these tests help reduce the hands-on time, minimize infection detection time, and are easy to use. Conventional systems often used to provide false-positive results, which led to the development of advanced devices that have helped reduce false-positive results by 10%. These advanced systems have also reduced the duration of infection detection from 4-5 days to a 24-hour period for positive results.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Roche Diagnostics
- ThermoFisher Scientific
- AB Sciex
- Beckman Coulter
- Dade Behring¸ Eurogentec
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by application
PART 07: Market segmentation by technology
PART 08: Market segmentation by product
PART 09: Market segmentation by end-user
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Major vendors
PART 18: Appendix
PART 19: About the Author
For more information about this report visit http://www.researchandmarkets.com/research/7zh5r8/global_blood
Related Topics: Infectious Disease Testing
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-blood-culture-tests-market-cagr-growth-of-725-by-2020---trends-technologies--opportunities-report-2016-2020---key-vendors-beckman-coulter-ab-sciex-thermofisher-scientific-300324690.html
SOURCE Research and Markets